Menu Search
Equities

Epam Systems Inc

E3M:BRN

Epam Systems Inc

Actions
  • Price (CHF)157.24
  • Today's Change0.00 / 0.00%
  • Shares traded60.00
  • 1 Year change--
  • Beta--
Data delayed at least 15 minutes, as of Jun 14 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

EPAM Systems, Inc. provides digital engineering, cloud, and artificial intelligence-enabled transformation services. The Company's software product and platform development services, including product research, customer experience design and prototyping, program management, component design and integration, full lifecycle software testing, product deployment and end-user customization, performance tuning, product support and maintenance, managed services, as well as cross-platform migration and modernizing legacy platforms. Its segments include North America, Europe, and Russia. It offers complex software product development services to address the constant need for innovation and agility among software and technology companies. It partners with global pharmaceutical, medical and scientific technology, biotechnology companies and retail pharmacies to deliver sophisticated scientific informatics and enterprise technology solutions. It also offers health data analytics.

  • Revenue in USD (TTM)4.64bn
  • Net income in USD446.39m
  • Incorporated2002
  • Employees53.15k
  • Location
    Epam Systems IncSUITE 202, 41 UNIVERSITY DRIVENEWTOWN 18940United StatesUSA
  • Phone+1 (267) 759-9000
  • Fax+1 (267) 759-8989
  • Websitehttps://www.epam.com/
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status		EPAM:NYQ since
announced		Transaction
value
FD Technologies PLC-First Derivative BusinessAnnounced07 Oct 202407 Oct 2024Announced23.90%301.67m
Neoris USA IncDeal completed04 Sep 202404 Sep 2024Deal completed25.81%--
Vates SADeal completed26 Mar 202426 Mar 2024Deal completed-8.08%--
Data delayed at least 15 minutes, as of Nov 13 2024.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.